SOLICITATION NOTICE
68 -- recombinant Protective Antigen (rPA) anthrax vaccine for the strategic national stockpile
- Notice Date
- 5/9/2008
- Notice Type
- Modification/Amendment
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority 330 Independence Avenue, SW, Rm G640, Washington, DC, 20201, UNITED STATES
- ZIP Code
- 20201
- Solicitation Number
- RFP-BARDA-08-15
- Response Due
- 5/29/2008
- Point of Contact
- Brian K Goodger, Phone: 202-260-0333
- E-Mail Address
-
Brian.Goodger@hhs.gov
- Small Business Set-Aside
- N/A
- Description
- The United States Government (USG) has a need to acquire and supply the Strategic National Stockpile (SNS) with 25 million doses of Final Drug Product (FDP) of recombinant protective antigen (rPA) anthrax vaccine. The FDP shall be packaged as single dose units or multi-dose vials with a minimum expiry period of 24 months manufactured in accordance with current Good Manufacturing Practice (cGMP). The rPA anthrax vaccine will initially be accepted into the SNS once the successful Offeror has supplied sufficient safety, efficacy, and stability data to support FDA (Food & Drug Administration)/CBER (Center for Biologics Evaluation & Research) Current Thinking for the potential use under a declared emergency under Emergency Use Authorization (EUA) for a post exposure prophylaxis indication (PEP), concurrent with antibiotics indication. The successful Offeror will be required to seek and achieve licensure for their rPA anthrax vaccine. Initial licensed product will be used in a pre-exposure general use prophylaxis (GUP) indication in adults. The Contractor shall also seek label extension for PEP plus antibiotic indication in adults in the base contract. The Government intends to have a full & open competition for this requirement in the form of a Request For Proposal (RFP). This synopsis is not a RFP; an RFP is anticipated on February 29, 2008, with proposal submission in May 29, 2008. The Government expects to make 1 or more awards, subject to the availability of funds, on or about September 26, 2008. Comments to this announcement, referencing synopsis RFP-BARDA-08-15 may be submitted to Brian K. Goodger, Contracting Officer at 202-260-0333 or in writing to Brian.Goodger@hhs.gov This proposed acquisition is subject to the availability of Project BioShield Funds.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=489a3fdb81ccad8b6a401671bdd719f2&tab=core&_cview=1)
- Place of Performance
- Address: TBD
- Zip Code: 00000
- Record
- SN01570216-W 20080511/080509215901-489a3fdb81ccad8b6a401671bdd719f2 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |